Literature DB >> 7933427

Management of heart failure. II. Counseling, education, and lifestyle modifications.

K Dracup1, D W Baker, S B Dunbar, R A Dacey, N H Brooks, J C Johnson, C Oken, B M Massie.   

Abstract

OBJECTIVE: This article reviews the role of counseling, education, dietary modifications, and exercise for patients with heart failure due to left ventricular systolic dysfunction. DATA SOURCE: We reviewed studies published in English between 1966 and 1993 and referenced in MEDLINE or EMBASE. We used the search terms heart failure, congestive; congestive heart failure; heart failure; cardiac failure; and dilated cardiomyopathy in conjunction with terms for the specific areas of interest. Where data were lacking, we relied on opinions of panel members and peer reviewers. STUDY SELECTION AND DATA SYNTHESIS: Studies were reviewed to determine whether patients had heart failure due to systolic dysfunction (left ventricular ejection fraction, < 0.35 to 0.40) and whether clinical outcomes were reported. Studies that reported only intermediate outcomes (eg, hemodynamics) were not reviewed.
CONCLUSION: Counseling and education can improve patient outcomes and decrease unnecessary hospitalizations. Patients with mild to moderate heart failure should be restricted to 3 g/d of sodium initially. Those who are unresponsive to this dosage or who have more severe disease should be advised to consume 2 g/d or less. Patients should be strongly advised to drink no more than 30 mL/d of alcohol or, preferably, to abstain completely. Exercise training is safe and can improve exercise duration and symptoms. Adherence to the treatment plan should be stressed and monitored at each visit. Clinicians should inform patients of the seriousness of their disease and their prognosis, but they should emphasize that patients can continue to remain active and enjoy a reasonable quality of life.

Entities:  

Mesh:

Year:  1994        PMID: 7933427     DOI: 10.1001/jama.1994.03520180066037

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  12 in total

1.  Development of a servo-controller of heart rate using a cycle ergometer.

Authors:  T Kawada; Y Ikeda; H Takaki; M Sugimachi; O Kawaguchi; T Shishido; T Sato; W Matsuura; H Miyano; K Sunagawa
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 2.  Nonpharmacologic options for the management of heart failure.

Authors:  Robin J Trupp; William T Abraham
Journal:  Curr Cardiol Rep       Date:  2003-05       Impact factor: 2.931

Review 3.  Prevention of relapse in patients with congestive heart failure: the role of precipitating factors.

Authors:  J Feenstra; D E Grobbee; F A Jonkman; A W Hoes; B H Stricker
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

4.  Pharmaceutical care of patients with heart failure.

Authors:  A Sadik; M Yousif; J C McElnay
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

5.  Factors contributing to the hospitalization of patients with congestive heart failure.

Authors:  M H Chin; L Goldman
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

Review 6.  Exercise training and heart failure: a systematic review of current evidence.

Authors:  Ffion Lloyd-Williams; Frances S Mair; Maria Leitner
Journal:  Br J Gen Pract       Date:  2002-01       Impact factor: 5.386

7.  Knowledge and communication difficulties for patients with chronic heart failure: qualitative study.

Authors:  A E Rogers; J M Addington-Hall; A J Abery; A S McCoy; C Bulpitt; A J Coats; J S Gibbs
Journal:  BMJ       Date:  2000-09-09

8.  Quality of life in patients with heart failure: ask the patients.

Authors:  Seongkum Heo; Terry A Lennie; Chizimuzo Okoli; Debra K Moser
Journal:  Heart Lung       Date:  2008-09-19       Impact factor: 2.210

9.  Effects of an interactive CD-program on 6 months readmission rate in patients with heart failure - a randomised, controlled trial [NCT00311194].

Authors:  Agneta Björck Linné; Hans Liedholm
Journal:  BMC Cardiovasc Disord       Date:  2006-06-24       Impact factor: 2.298

10.  Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy.

Authors:  I Shureiqi; S B Cantor; S M Lippman; D E Brenner; M E Chernew; A M Fendrick
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.